Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial
一项开放标签试验,旨在评估一种含有协同比例干扰素α-2b和γ的新制剂(HeberPAG)在蕈样肉芽肿患者中的药代动力学和药效学特征。该制剂含有协同比例的干扰素α-2b和γ。
期刊:
影响因子:
doi:10.1186/2050-6511-13-20
García-Vega, Yanelda; García-García, Idrian; Collazo-Caballero, Sonia E; Santely-Pravia, Egla E; Cruz-Ramírez, Alieski; Tuero-Iglesias, Angela D; Alfonso-Alvarado, Cristian; Cabrera-Placeres, Mileidys; Castro-Basart, Nailet; Duncan-Roberts, Yaquelín; Carballo-Treto, Tania I; Soto-Matos, Josanne; Izquierdo-Toledo, Yoandy; Vázquez-Blomquist, Dania; García-Iglesias, Elizeth; Bello-Rivero, Iraldo